Corus制药控股 CRBP 深 沪
已收盘 12-19 16:00:00 美东时间
8.12
+0.020
+0.25%
华盛通- 最 高11.98
- 今 开8.15
- 成交量 19.01万股
- 最 低 7.971
- 昨 收 8.10
- 总市值 10.15亿
- 52周最高 20.56
- 市盈率 静 --
- 换手率 0.15%
- 52周最低 4.64
- 委 比 95.52%
- 总股本 1.25亿
- 历史最高 61.90
- 量 比 0.55
- 振 幅 49.49%
- 历史最低 0.05
- 每 手 1
- 风险率 2.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Corbus Pharmaceuticals Holdings shares are trading lower after the company announced a proposed public offering.
Corbus Pharmaceuticals Holdings shares are trading lower after the company anno...
10-31 04:49
稳定币赛道未来格局：合规稳定币+离岸稳定币+去中心化稳定币
稳定币市场未来将呈现“百币大战”，尽管USDT和USDC仍为龙头，但还将有大量腰尾部稳定币，涵盖Web2合规稳定币和Web3去中心化稳定币，分别满足细分市场和创新需求。
06-27 01:03
供应量超过 2463.82 亿美元 以太坊如何承载稳定币的广泛应用？
2025年稳定币市场持续高速增长，总供应量达2463.82亿美元。USDT和USDC占据主导，USDT占比62%，USDC应用广泛且合规。新兴稳定币如USDE、USD1等崛起。以太坊生态中，稳定币在交易、借贷和支付等场景应用活跃，监管方面香港、美国和欧盟正实施严格法规。
05-29 12:01
Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference
Caribou Biosciences' CEO, Rachel Haurwitz, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4th at 9:20 AM EDT. More details and a webcast link are available on Caribou's website.
05-28 20:00
Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Corbus Pharmaceuticals CEO Yuval Cohen will present a corporate update at the Jefferies Global Healthcare Conference on June 4, 2025, and participate in investor meetings. The company focuses on oncology and obesity with a pipeline including CRB-701, CRB-601, and CRB-913.
05-22 12:00
SharkNinja, Inc. (SN US) ：有望进一步验证基本面“线性外推”逻辑 | 兴·研究
一周研报 华兴证券“兴·研究”为您摘编华兴证券研究所上周研报精华，助您全面了解海内外经济走势，透析细分市场热点。 华兴证券研究所依托华兴资本集团与华兴证券在新经...
03-03 14:02
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 28.2% to $5.16 during ...
2024-09-25 22:42
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose. However, investors reacted to limited gains at higher doses. Corbus Pharmaceuticals and Skye Bioscience stocks dropped as all three companies explore CB1 inhibition in obesity treatment.
2024-09-21 03:18
Crude Oil Moves Higher; Sable Offshore Shares Slide
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Comp...
2024-09-21 02:16
